Clinical Trials Browser

OTHER × Head and Neck Neoplasms × Radiation Dose Hypofractionation × Clear all

NCT07447570 2026-03-03

Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06536699 2024-08-05

HYPORT-HN

Phase NA Not yet recruiting

Head and Neck Neoplasms

NCT02201355 2021-02-02

Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck

Phase 1 Terminated

Head and Neck Neoplasms